ESTROPA Trademark

Trademark Overview


On Friday, March 27, 2015, a trademark application was filed for ESTROPA with the United States Patent and Trademark Office. The USPTO has given the ESTROPA trademark a serial number of 86578412. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 2, 2017. This trademark is owned by Glaxo Group Limited. The ESTROPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
estropa

General Information


Serial Number86578412
Word MarkESTROPA
Filing DateFriday, March 27, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 2, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe English translation of "ESTROPA" in the mark is "stanza of a poem".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 20, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, October 2, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 2, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2017EXTENSION 1 GRANTED
Monday, February 27, 2017EXTENSION 1 FILED
Monday, February 27, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 17, 2016ASSIGNED TO LIE
Wednesday, May 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 12, 2015NON-FINAL ACTION E-MAILED
Saturday, December 12, 2015NON-FINAL ACTION WRITTEN
Saturday, December 12, 2015REMOVED FROM TEAS PLUS
Friday, December 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 19, 2015NON-FINAL ACTION E-MAILED
Friday, June 19, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 17, 2015ASSIGNED TO EXAMINER
Monday, April 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 31, 2015NEW APPLICATION ENTERED IN TRAM